Freight Technologies (NASDAQ: FRGT), a technology-driven logistics company powered by its proprietary artificial intelligence (“AI”) and machine learning Fr8App platform has been selected by Amazon Mexico (Amazon.com Inc. (NASDAQ: AMZN) again for its logistical solutions. Fr8App uniquely provides a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping within the United States, Mexico, and Canada (“USMCA”)…
Nextech3D.AI (CSE: NTAR) (OTCQX: NEXCF) (FSE: EP2), a generative AI-powered 3D model supplier for Amazon, P&G, Kohl’s and other major e-commerce retailers, today announced the granting of a patent by USPTO for 3D model generation from Computer Aided Design (“CAD”) data. Nextech3D.ai’s receipt of this first patent, as part of its previously announced portfolio of…
Correlate Energy (OTCQB: CIPI), a growth-oriented distributed energy company, has broken ground on its solar project in Reading, Pennsylvania. According to the announcement, the project originally started at 3.8 MW but has grown to 5.2 MW, making it the company’s largest project to date. In addition, when completed, the project will be one of the largest…
Diamond Lake Minerals (OTC: DLMI), which specializes in the development and support of digital assets and SEC-registered security tokens, was featured in a Benzinga Crypto article. The piece discusses DLMI’s pioneering efforts to integrate traditional assets into digital finance and its focus on SEC-registered security tokens to position in this landscape. “Diamond Lake Minerals currently…
Astrotech (NASDAQ: ASTC), an innovative science and technology company, has formed a new wholly owned subsidiary: Pro-Control Inc. According to the announcement, Pro-Control is unveiling its proprietary Pro-Control Maximum Value Process(TM) (Pro-Control MVP(TM) and the Pro-Control-1000(TM) mass spectrometer. The spectrometer has been designed to work within a chemical factory analyzing real-time samples while achieving optimized yields,…
Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, was featured in the most recent offering from the Bell2Bell Podcast. During the interview, host Stuart Smith and Vision Marine Technologies head of investor relations Bruce Nurse talked about the company and its innovation within the performance electric…
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products, has announced successful preclinical trial results of its innovative anti–IL–17 VHH antibody (“NanoAb”). The trial evaluated Scinai’s NanoAbs as a local treatment for the large and underserved population of mild to moderate plaque psoriasis. The study…
Turbo Energy (NASDAQ: TURB), a Valencia-based company specializing in photovoltaic energy storage solutions, today announced that Movistar has launched Turbo Energy’s GoSolar offering for sale this week through Movistar’s energy branch, Solar360. A telecommunications leader in Spain and Latin America, Movistar has been recognized as one of the world’s top 500 most valuable companies in…
Turbo Energy (NASDAQ: TURB), a Valencia-based company specializing in photovoltaic energy storage solutions, today announced that Movistar has launched Turbo Energy’s GoSolar offering for sale this week through Movistar’s energy branch, Solar360. A telecommunications leader in Spain and Latin America, Movistar has been recognized as one of the world’s top 500 most valuable companies in…
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products, is announcing the publication of a peer-reviewed article regarding NanoAbs. The article reports on data that supports the use of Scinai’s aerosolized NanoAbs as a platform for the treatment of hyperinflammatory viral diseases, which addresses significant…
Clene (NASDAQ: CLNN), together with its wholly owned subsidiary Clene Nanomedicine Inc., recently provided operating highlights for its amyotrophic lateral sclerosis (“ALS”) clinical program. “In August, Clene reported a 24-month long-term data cut from the open-label extension (‘OLE’) of the RESCUE-ALS study as of July 2023, which showed a significant median survival benefit of 19.3…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has filed a spoofing complaint in the U.S. District Court for the Southern District of New York. The complaint, filed on Dec. 6, 2023, alleges that UBS Securities LLC, IMC Financial Markets and Clear Street Markets LLC engaged in a scheme using spoofing to manipulate…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is planning to submit an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) in the next 45 days. The application is for the company’s planned U.S. phase 1b Hypertension Clinical Trial. The filing had been delayed for necessary documentation…
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) will be featured in an upcoming BTV – Business Television interview. The episode is scheduled to air on FOX Business News at 5:30 p.m. ET on Dec. 10, 2023. In the segment, “BTV highlights the company’s significant progress in its innovative silver-tin polymetallic venture in Bolivia. With…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its filing of a complaint in the United States District Court for the Southern District of New York alleging that UBS Securities, LLC, IMC Financial Markets and Clear Street Markets, LLC (the “Defendants”) engaged in a market manipulation scheme that violated Section 10(b)…
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has released a fireside chat video with CEO and chair Howard Weisman. During the company update video, Weisman outlines the company’s recent achievement and reiterates PaxMedica’s focus on developing groundbreaking therapies and transformative solutions. Specifically, Weisman provided a summary of the company’s…
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. In September, the company announced that 200 out of 243 expected patients had been enrolled in its ongoing study evaluating the effectiveness of Berubicin for recurrent glioblastoma (“GBM”), a highly aggressive and incurable…
Correlate (OTCQB: CIPI), a company at the forefront of the clean distributed energy revolution, was featured in a comprehensive research report by Harbinger Research, LLC. Dated Oct. 31, 2023, the piece sheds light on Correlate, underscoring its potential in an industry ripe for growth and innovation. “As the global commitment to combatting climate change strengthens,…